Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01282424
Brief Title: Efficacy and Safety Study of Idelalisib in Subjects With Indolent B-Cell Non-Hodgkin Lymphoma (DELTA)

First Submitted : January 21, 2011
First Submitted that Met QC Criteria : January 24, 2011
First Posted : January 25, 2011 (Estimate)

Results First Submitted : August 22, 2014
Results First Submitted that Met QC Criteria : August 22, 2014
Results First Posted : September 4, 2014 (Estimate)

Certification/Extension First Submitted : March 20, 2014
Certification/Extension First Submitted that Met QC Criteria : March 20, 2014
Certification/Extension First Posted : April 16, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : October 19, 2018
Last Update Posted : November 19, 2018